December 12, 2024 18:35 (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Bangladesh: Court defers bail hearing of Hindu priest Chinmoy Krishna Das for one month | Sambhal incident is BJP's conspiracy: Akhilesh Yadav in Lok Sabha | Mahayuti likely to name Devendra Fadnavis as Maharashtra CM tomorrow | INDIA bloc cracks visible in Parliament as SP and TMC skip Adani protests | 'I am the final word': Mamata Banerjee reminds TMC leaders of her absolute authority in party amid 'power-struggle' | India calls Bangladesh mission's breach in Agartala 'deeply regrettable' | BJP appoints observers for meeting to decide next Maharashtra chief minister | PM Modi watches 'The Sabarmati Report', Vikrant Massey says 'highest point in my life' | Akal Takht punishes Sukbir Singh Badal with toilet cleaning duties over 2015 sacrilege case | What's going on?: Supreme Court questions Senthil Balaji's reinstatement as Tamil Nadu minister immediately after bail

China to make COVID-19 vaccine global public good: Official

Jun 07, 2020, at 01:23 pm

Beijing/Xinhua: China will make its COVID-19 vaccine a global public good when it is ready for application after successful research and clinical trials, a senior Chinese official said Sunday.

‘Global solidarity’ needed, to find affordable, accessible COVID-19 vaccine

Jun 05, 2020, at 09:12 am

New York: In the race to end the coronavirus pandemic, the UN chief reminded a virtual medical conference on Thursday that “a vaccine, by itself, is not enough”.

First human trial of COVID-19 vaccine finds it is safe and induces rapid immune response

May 23, 2020, at 08:50 am

New York/IBNS: The first COVID-19 vaccine to reach phase 1 clinical trial has been found to be safe, well-tolerated, and able to generate an immune response against SARS-CoV-2 in humans, according to new research published in The Lancet.

COVID-19: Moderna announces positive interim phase 1 data for its mRNA Vaccine

May 19, 2020, at 04:59 pm

New York/IBNS: Moderna, Inc.,  a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, has announced positive interim clinical data of mRNA-1273, its vaccine candidate against novel coronavirus (SARS-CoV-2), from the Phase 1 study led by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH).

ICMR partners with BBIL to develop indigenous COVID-19 vaccine

May 10, 2020, at 02:10 am

New Delhi/IBNS: The Indian Council of Medical Research (ICMR) on Saturday announced to partner with the Bharat Biotech International Limited (BBIL) to develop a fully indigenous vaccine for Covid-19 using the virus strain isolated at ICMR's National Institute of Virology (NIV) in Pune, reports said.

IIT-G collaborates with Hester Biosciences Limited to develop vaccine against COVID-19

Apr 29, 2020, at 02:57 pm

Guwahati/IBNS: Indian Institute of Technology, Guwahati (IIT-G) is collaborating with Hester Biosciences Limited – a pharmaceutical company based in Ahmedabad in Gujarat, to work on the vaccine development against COVID-19.

Israeli scientist claims COVID-19 vaccine is two-third ready

Apr 20, 2020, at 05:44 pm

Jerusalem/IBNS: Giving a ray of hope to the world, an Israeli scientist has claimed that he is two-thirds into developing a vaccine for COVID-19.